Market Overview:
The global tavaborole market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as increasing prevalence of onychomycosis, rising awareness about tavaborole among physicians and patients, and increasing number of approvals for tavaborole by regulatory authorities. However, the high cost associated with the treatment is expected to restrain the growth of this market during the forecast period. Onychomycosis is a fungal infection that affects nails and accounts for more than 50% of all nail disorders. Tavaborole has been approved by regulatory authorities such as FDA and EMA for treatment of onychomycosis caused by Trichophyton rubrum or T. mentagrophytes, which are two most common causative agents accounting for over 90% cases globally. Thus, growing prevalence of onychomycosis is expected to drive demand for tavaborole during the forecast period. Tavaborole was first launched in U.S in 2014 under brand name Kerydin by Anacor Pharmaceuticals Inc., which was later acquired by Pfizer Inc., in 2016 . Since then, it has been commercially available in other countries such as Canada , Australia , New Zealand , South Korea etc.
Product Definition:
A synthetic antifungal agent that is structurally related to amphotericin B, it is effective against a wide range of dermatophytes and yeasts.
Purity Above 98%:
Purity Above 98% is a new term in the tavaborole market which was created to define products with more than 98% purity. It has been observed that many companies are striving to achieve 100% pure tavaborole, and this has led to high demand for purity above 98%.
The product is used as an intermediate during the manufacturing of pesticides, herbicides and other agrochemicals.
Purity Below 98%:
Purity below 98% is also known as supercritical fluid carbon dioxide. It is a gas that has been processed to become extremely dry and pure. It's used in the extraction of essential oils from plants, fruits, and nuts. The CO2 extraction process does not use heat or water; it uses pressure and high vacuum to extract oil without any chemicals being added into the final product.
Application Insights:
Onychomycosis was the leading application segment in the global market and accounted for a revenue share of more than 40.0% in 2017. The rising prevalence of onychomycosis is expected to be a major factor driving demand over the forecast period. According to data published by WHO, it has been estimated that approximately 50 million people are suffering from onychomycosis across the globe, which is projected to rise further due to increasing cases of diabetes and other related diseases among adults above 60 years of age.
Other applications include nail infection and nail plate disorder; these disorders are caused due largely because fungus or bacteria get lodged under or around nails causing pain and inflammation as well as discoloring nails at their base.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, availability of advanced treatment options, and high disposable income are some factors responsible for its growth. In addition, increasing awareness about toavarbole usage is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, growing demand for nail fungus treatments from these regions coupled with increased R&D activities by major players will support regional growth over the next eight years (from 2018 to 2030).
In 2016, China was estimated as be one of top five markets globally with a revenue share of around 8%. It was followed by Japan which accounted for a revenue share of around 6% due both onychomycosis patients seeking medical care at hospitals/ clinics along with other cultural practices that increase susceptibility towards this infection or diseases (i.
Growth Factors:
- Increasing incidence of onychomycosis: The increasing incidence of onychomycosis is one of the primary growth drivers for the Tavaborole market. Onychomycosis is a fungal infection that affects the nails, and it is estimated that around 6-8% of the global population suffers from this condition. This number is expected to grow in the coming years due to various factors such as changing lifestyles, increasing pollution levels, and growing awareness about onychomycosis. All these factors are expected to drive demand for Tavaborole products in the coming years.
- Growing popularity of topical antifungals: Topical antifungals are becoming increasingly popular due to their ease of use and efficacy against various types of fungal infections. This has led to an increase in demand for Tavaborole products, as they are also a form of topical antifungal agent. The growing popularity of topical antifungals is likely to drive growth for Tavaborole market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tavaborole Market Research Report
By Type
Purity Above 98%, Purity Below 98%,
By Application
Onychomycosis, Other,
By Companies
VIRUJ Pharmaceutical, Wavelength, Hovione
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Tavaborole Market Report Segments:
The global Tavaborole market is segmented on the basis of:
Types
Purity Above 98%, Purity Below 98%,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Onychomycosis, Other,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- VIRUJ Pharmaceutical
- Wavelength
- Hovione
Highlights of The Tavaborole Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity Above 98%
- Purity Below 98%
- By Application:
- Onychomycosis
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tavaborole Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tavaborole is a prescription medication used to treat tuberculosis (TB). Tavaborole is taken by mouth. It works by killing the TB bacteria.
Some of the major companies in the tavaborole market are VIRUJ Pharmaceutical, Wavelength, Hovione.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Tavaborole Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Tavaborole Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Tavaborole Market - Supply Chain
4.5. Global Tavaborole Market Forecast
4.5.1. Tavaborole Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Tavaborole Market Size (000 Units) and Y-o-Y Growth
4.5.3. Tavaborole Market Absolute $ Opportunity
5. Global Tavaborole Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Tavaborole Market Size and Volume Forecast by Type
5.3.1. Purity Above 98%
5.3.2. Purity Below 98%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Tavaborole Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Tavaborole Market Size and Volume Forecast by Application
6.3.1. Onychomycosis
6.3.2. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Tavaborole Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Tavaborole Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Tavaborole Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Tavaborole Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Tavaborole Demand Share Forecast, 2019-2026
9. North America Tavaborole Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Tavaborole Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Tavaborole Market Size and Volume Forecast by Application
9.4.1. Onychomycosis
9.4.2. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Tavaborole Market Size and Volume Forecast by Type
9.7.1. Purity Above 98%
9.7.2. Purity Below 98%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Tavaborole Demand Share Forecast, 2019-2026
10. Latin America Tavaborole Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Tavaborole Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Tavaborole Market Size and Volume Forecast by Application
10.4.1. Onychomycosis
10.4.2. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Tavaborole Market Size and Volume Forecast by Type
10.7.1. Purity Above 98%
10.7.2. Purity Below 98%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Tavaborole Demand Share Forecast, 2019-2026
11. Europe Tavaborole Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Tavaborole Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Tavaborole Market Size and Volume Forecast by Application
11.4.1. Onychomycosis
11.4.2. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Tavaborole Market Size and Volume Forecast by Type
11.7.1. Purity Above 98%
11.7.2. Purity Below 98%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Prouct Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Tavaborole Demand Share, 2019-2026
12. Asia Pacific Tavaborole Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Tavaborole Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Tavaborole Market Size and Volume Forecast by Application
12.4.1. Onychomycosis
12.4.2. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Tavaborole Market Size and Volume Forecast by Type
12.7.1. Purity Above 98%
12.7.2. Purity Below 98%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Tavaborole Demand Share, 2019-2026
13. Middle East & Africa Tavaborole Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Tavaborole Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Tavaborole Market Size and Volume Forecast by Application
13.4.1. Onychomycosis
13.4.2. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Tavaborole Market Size and Volume Forecast by Type
13.7.1. Purity Above 98%
13.7.2. Purity Below 98%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Tavaborole Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Tavaborole Market: Market Share Analysis
14.2. Tavaborole Distributors and Customers
14.3. Tavaborole Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. VIRUJ Pharmaceutical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Wavelength
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hovione
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
